Skip to main content
SpringerLink
Log in

Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors expression

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

This study examined the potential roles of astragalus and angiotensin II: type 2 receptor (AT2) in rats with streptozotocin (STZ)-induced diabetic cardiomyopathy. Of 52 female 4-weekold Wistar rats treated with high glucose and lipid diet to induce insulin resistance, 7 treated with sodium citrate buffer (pH=4.5) served as controls (con1) and the other 45 were treated by intraperitoncal injection (ip) of STZ to induce type 2 diabetes. After 20 weeks, the maximal velocity decrease of pressure per second in left ventricle within the period of isovolumic relaxation (−dp/dtmax was detected by inserting cannula through right carotid artery. Of the 45 rats, 24 with −dp/dtmax 700 mmHg/s (1 mmHg=0.133 kPa) developing diabetic cardiomyopathy were grouped as follows: 7 treated with double distilled H2O (ip) were included in control group 2 (con2); other 8 treated with AT2 agonist (CGP42112A, ip) were included in experimental groupl (exp); 9 treated with astragalus (po) constituted experimental group 2 (exp2). All injections lasted 4 weeks (qd) and the heart weight (HW) was recorded. Cardiomyocyte apoptosis index (CAI), mRNA of AT2 and Bel-2 as well as AT2 and Bcl-2 protein values in cardiomyocytes were also measured. Our results showed that −dp/dtmax in expl, exp2 and con2 were much lower than those in con1 (P<0.01). CAI and AT2 in both mRNA and protein in con1 were lower than those in the other three groups (P<0.01). The three parameters above were higher in expl but less in exp2 than those in con2, respectively (P<0.01). The three parameters and HW in expl were much higher than those in exp2 (P<0.01). Changes of Bcl-2 were opposite to those of AT2. Our results suggested that high expression of AT2 might accelerate the apoptosis of cardiomyocytes in diabetic rats and play an important role in precipitating diabetic cardiomyopathy and astragalus protects diabetic rats from developing cardiomyopathy by downregulating AT2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hamby R, Zoneraim S, Sherman L. Diabetic cardiomyopathy. JAMA, 1974, 229: 1749

    Article  CAS  PubMed  Google Scholar 

  2. Thompson E W. Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatment. Am J Ana, 1988, 182: 270

    Article  CAS  Google Scholar 

  3. Zhu X X, Zhou X P, Zhong X Let al. Streptozocin induced cardiomyopathy in diabetic rats. Chin Med J, 1993, 106: 463

    CAS  PubMed  Google Scholar 

  4. Fein F S, Komstein L B, Strobecket J Eet al. Altered myocardial mechanics in diabetic rats. Cir Res, 1980; 47: 922

    Article  CAS  Google Scholar 

  5. Tahilini A G, Vadlamudi R V S V, MeNell A J H. Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment. Can J Physiol Pharmacol, 1983, 61: 516

    Article  Google Scholar 

  6. Ni Z S, Zheng J C, Wang D Wet al. Primary study on the mRNA expression of angiotensin II type 2 receptor and cytokines in the kidney of diabetic rats (Chinese). Chin J Chin Herbs, 2004, 23(1): 54

    Google Scholar 

  7. Ichihi S, Senbonmatsu T, Edward Pet al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II induced hypertension. Circulation, 2001, 104: 346

    Article  Google Scholar 

  8. Matsumoto T, Ozono R, Oshima Tet al. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovas Res, 2002, 46: 73

    Article  Google Scholar 

  9. Horiuchi M, Akishita M, Victor Jet al. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension, 1999, 33: 613

    Article  CAS  PubMed  Google Scholar 

  10. Zhou J Y, Fan Y, Kong J Let al. Effect of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats (Chinese). Chin J Chin Herbs, 2000, 25(5): 300

    CAS  Google Scholar 

  11. Hu Y C, Hou J Y. Study on effect of Zhimu combined astragalus on improving renal hypertension rats cardiac dysfunction (Chinese). Chin J Chin Herbs, 2002, 27 (11): 858 (Continued from page 368)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China

    Li Changyun, Cao Linsheng & Zeng Qiutang

Authors
  1. Li Changyun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cao Linsheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zeng Qiutang
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

LI Changyun, male, born in 1967, M. D., Ph. D.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Changyun, L., Linsheng, C. & Qiutang, Z. Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors expression. Current Medical Science 24, 379–384 (2004). https://doi.org/10.1007/BF02861873

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02861873

Key words

Search

Navigation